Combinatorial inhibition of PTPN12-regulated receptors leads to a broadly effective therapeutic strategy in triple-negative breast cancer.

作者： Rachel Schiff , James G Christensen , David J Shields , Mothaffar F Rimawi , Matthew J Ellis

关键词: Text mining 、 Receptor 、 Medicine 、 Receptor tyrosine kinase 、 Triple-negative breast cancer 、 Cancer research 、 Therapeutic strategy 、 Broad spectrum 、 Breast cancer

摘要: Targeting tyrosine kinase receptors that share the feedback inhibitor PTPN12 leads to broad spectrum therapeutic suppression of triple-negative breast cancer.

参考文章(52)

Carey K. Anders, Timothy M. Zagar, Lisa A. Carey, The Management of Early-Stage and Metastatic Triple-Negative Breast Cancer: A Review Hematology-oncology Clinics of North America. ,vol. 27, pp. 737- 749 ,(2013) , 10.1016/J.HOC.2013.05.003

Carey Anders, Lisa A Carey, Understanding and treating triple-negative breast cancer Oncology. ,vol. 22, pp. 1233- 91239401243 ,(2008)

Denise A. Yardley, Dianna L. Shipley, Nancy W. Peacock, Mythili Shastry, Rajiv Midha, Victor M. Priego, John D. Hainsworth, Phase I/II trial of neoadjuvant sunitinib administered with weekly paclitaxel/carboplatin in patients with locally advanced triple-negative breast cancer. Breast Cancer Research and Treatment. ,vol. 152, pp. 557- 567 ,(2015) , 10.1007/S10549-015-3482-4

Peng Wu, Thomas E. Nielsen, Mads H. Clausen, Small-molecule kinase inhibitors: an analysis of FDA-approved drugs. Drug Discovery Today. ,vol. 21, pp. 5- 10 ,(2016) , 10.1016/J.DRUDIS.2015.07.008

S.A. Forbes, G. Bhamra, S. Bamford, E. Dawson, C. Kok, J. Clements, A. Menzies, J.W. Teague, P.A. Futreal, M.R. Stratton, The Catalogue of Somatic Mutations in Cancer (COSMIC). Current protocols in human genetics. ,vol. 57, ,(2008) , 10.1002/0471142905.HG1011S57

Xun Cao, Yan-Zhen Chen, Ruo-Zhen Luo, Lin Zhang, Song-Liang Zhang, Jun Zeng, Yu-Chuan Jiang, Yu-Jing Han, Zhe-Sheng Wen, Tyrosine-protein phosphatase non-receptor type 12 expression is a good prognostic factor in resectable non-small cell lung cancer Oncotarget. ,vol. 6, pp. 11704- 11713 ,(2015) , 10.18632/ONCOTARGET.3588

Yuan Xunyi, Yuan Zhentao, Jiang Dandan, Li Funian, Clinicopathological significance of PTPN12 expression in human breast cancer Brazilian Journal of Medical and Biological Research. ,vol. 45, pp. 1334- 1340 ,(2012) , 10.1590/S0100-879X2012007500163

Olivier Lichtarge, Keith R Yamamoto, Fred E Cohen, Identification of functional surfaces of the zinc binding domains of intracellular receptors. Journal of Molecular Biology. ,vol. 274, pp. 325- 337 ,(1997) , 10.1006/JMBI.1997.1395

Ola Söderberg, Mats Gullberg, Malin Jarvius, Karin Ridderstråle, Karl-Johan Leuchowius, Jonas Jarvius, Kenneth Wester, Per Hydbring, Fuad Bahram, Lars-Gunnar Larsson, Ulf Landegren, Direct Observation of Individual Endogenous Protein Complexes in Situ by Proximity Ligation Nature Methods. ,vol. 3, pp. 995- 1000 ,(2006) , 10.1038/NMETH947

10.

Hans Prenen, Jan Cools, Nicole Mentens, Cedric Folens, Raf Sciot, Patrick Schöffski, Allan Van Oosterom, Peter Marynen, Maria Debiec-Rychter, Efficacy of the kinase inhibitor SU11248 against gastrointestinal stromal tumor mutants refractory to imatinib mesylate. Clinical Cancer Research. ,vol. 12, pp. 2622- 2627 ,(2006) , 10.1158/1078-0432.CCR-05-2275

Combinatorial inhibition of PTPN12-regulated receptors leads to a broadly effective therapeutic strategy in triple-negative breast cancer.

来源期刊

我的账户

Combinatorial inhibition of PTPN12-regulated receptors leads to a broadly effective therapeutic strategy in triple-negative breast cancer.

来源期刊

相似文章 10

我的账户